Company receives acceptability, in principle, for ZyVac TCV making it eligible for purchase by United Nations procurement agencies
The issue with a face value of Rs 10 per equity share consists of a fresh issue of equity shares worth up to Rs 400 crore
The supplements are made using only vegetarian-sourced ingredients
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The interim efficacy readout, involving around 170 participants with 15-month data, remains on track for the end of March 2026
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Owlet’s push comes as parents demand smarter, more dependable nursery tech
Topline results from the Phase 2 VISTA trial show that PIPE-307 did not meet its primary or secondary efficacy endpoints
Subscribe To Our Newsletter & Stay Updated
